Related Experiment Video
Updated: May 3, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Intermittent versus daily therapy for treating tuberculosis in children
Anuradha Bose1, Soumik Kalita, Winsley Rose
1Department of Community Health, Christian Medical College, Vellore, India, 632002.
Current evidence is insufficient to determine if intermittent or daily treatment is better for childhood tuberculosis (TB). More research is needed to inform optimal TB treatment regimens for children.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Childhood tuberculosis (TB) is a significant global health issue.
- While daily, six-month rifampicin-containing regimens are effective, poor adherence hinders treatment success.
- Intermittent regimens show potential for better adherence, but their efficacy compared to daily treatment remains unclear.
Purpose of the Study:
- To compare the efficacy and safety of intermittent (twice- or thrice-weekly) versus daily short-course anti-TB regimens in treating childhood TB.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) and quasi-RCTs involving children (≤15 years) diagnosed with TB.
- Searched multiple databases and trial registries up to May 2013 without language restrictions.
- Included trials using rifampicin-containing regimens for at least two months, comparing intermittent to daily treatment.
Main Results:
- Four trials (563 children) compared twice-weekly intermittent to daily regimens; no significant difference in cure rates was detected (very low quality evidence).
- Trials were too small and used non-standard regimens, limiting conclusions on cure, death, relapse, and adverse events.
- Adherence rates were similar between intermittent and daily regimens (87% vs. 84%).
- No trials compared the commonly used thrice-weekly regimen with daily treatment.
Conclusions:
- Existing trials are insufficient to support or refute intermittent short-course TB treatment over daily regimens in children.
- Further high-quality randomized trials in high TB-transmission settings are necessary to guide policy and practice.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...

